FOLH1 and prostate carcinoma: Used in combination, PSMA and metabolic tracers can provide different information about the status of prostate cancer cells, although it should be noted with all PET scanners that metastases smaller than the spatial resolution of the scanners or with activity below the current limits of detection may remain occult [38].